Trials / Withdrawn
WithdrawnNCT01470430
VEGF In Systemic Circulation Of ROP-infants
Study to Measure Systemic VEGF Levels in ROP Infants Following Intravitreal Anti-VEGF Therapy or Retinal Laser Treatment
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- University Hospital Freiburg · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to measure systemic levels of vascular endothelial growth factor (VEGF) and other proteins (e.g. IGF-1) in the systemic circulation of infants with retinopathy of prematurity (ROP) following ocular treatment with either intravitreal injections of anti-VEGF agents or retinal laser photocoagulation. The primary aim is to determine if serum VEGF levels change after treatment.
Conditions
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2014-03-01
- First posted
- 2011-11-11
- Last updated
- 2014-01-28
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01470430. Inclusion in this directory is not an endorsement.